ORAMED PHARMACEUTICALS INC. - 13 Jan 2025 SCHEDULE 13G Report for Scilex Holding Company Common Stock par value $0.0001 per share (SCLX)

Filing Manager: ORAMED PHARMACEUTICALS INC.
Reporting Manager: Oramed Pharmaceuticals Inc.
Security: Scilex Holding Company Common Stock par value $0.0001 per share
Symbol: SCLX
Shares outstanding: 250,000,000 shares
Disclosed Ownership: 15,500,000 shares
Ownership: 6.2%
Form type: SCHEDULE 13G
Filing time: 17 Jan 2025, 16:15:11 UTC
Date of event: 13 Jan 2025
Next filing: 08 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Oramed Pharmaceuticals Inc.	6.2%	15,500,000	15,500,000	0	/s/ Avraham Gabay	Avraham Gabay/Chief Financial Officer